How many insider trades does FilingIQ track for CELC?

FilingIQ tracks 135 Form 4 insider transactions for CELC (Celcuity Inc.), covering filings from Oct 26, 2017 onwards. 6 of those are dated within the last 90 days.

Are CELC insiders net buyers or net sellers?

Across the full Form 4 history for CELC, 14 transactions (10%) were open-market purchases and 57 (42%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does CELC insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ normalises insider identity across reporting variations and scores discretionary open-market purchases and sales on its multi-factor composite model.

What sector is CELC in?

Celcuity Inc. (CELC) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $4.90B.

CELC insider trading

NasdaqCM Healthcare

Celcuity Inc.: insider trade history from SEC Form 4 filings.

Total Form 4 trades

135

Last 90 days

Buys / sells

10% / 42%

Market cap

$4.90B

About Celcuity Inc.

Celcuity Inc., a clinical-stage biotechnology company, focuses on the development of targeted therapies for the treatment of various solid tumors in the United States. The company's lead drug candidate includes Gedatolisib, which selectively targets various Class I isoforms of phosphatidylinositol-3-kinase (PI3K) and the two mechanistic targets of rapamycin (mTOR) sub-complexes, mTORC1 and mTORC2 to treat patients with hormone receptor positive (HR+), human epidermal growth factor receptor 2 negative (HER2-) or HR+/HER2-, advanced or metastatic breast cancer (ABC), and patients with metastatic castration resistant prostate cancer (mCRPC). It also engages in developing of CELsignia diagnostic platform. The company had a license agreement with Pfizer Inc. for the development and commercialization rights to Gedatolisib. Celcuity Inc. was founded in 2011 and is based in Minneapolis, Minnesota.

Company website: www.celcuity.com

CELC insider activity at a glance

FilingIQ tracks 135 insider transactions for CELC in filings since Oct 26, 2017. The most recent transaction is dated Oct 1, 2026.

Across the full history, 14 open-market purchases and 57 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on CELC insider trades is 53.9/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live CELC trades on FilingIQ Raw filings on SEC EDGAR

Latest CELC Form 4 filings

GRYSKA DAVID W

A Oct 5, 2026

Hahne Vicky Chief Financial Officer

A Aug 18, 2026

Laing Lance G. Chief Science Officer

A Aug 18, 2026

Sullivan Brian F. Chief Executive Officer

A Aug 18, 2026

BAKER BROS. ADVISORS LP

Most recent disclosures. Sign up to filter by score, transaction code, or insider role.

Other Healthcare tickers with recent insider activity

UTHR 820

UNITED THERAPEUTICS Corp

THERMO FISHER SCIENTIFIC INC.

NTRA 129

Natera, Inc.

ATTO 123

Attovia Therapeutics, Inc.

CORT 110

CORCEPT THERAPEUTICS INC

TEM 104

Tempus AI, Inc.

13F funds holding CELC

BAKER BROS. ADVISORS LP

$828.15M · 4.2% of AUM

Caption Management, LLC

$17.79M · 0.1% of AUM

Frequently asked

How many insider trades does FilingIQ track for CELC?: FilingIQ tracks 135 Form 4 insider transactions for CELC (Celcuity Inc.), covering filings from Oct 26, 2017 onwards. 6 of those are dated within the last 90 days.
Are CELC insiders net buyers or net sellers?: Across the full Form 4 history for CELC, 14 transactions (10%) were open-market purchases and 57 (42%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does CELC insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ normalises insider identity across reporting variations and scores discretionary open-market purchases and sales on its multi-factor composite model.
What sector is CELC in?: Celcuity Inc. (CELC) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $4.90B.

Methodology & sources

Every CELC insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.